2026 NPPES data Neurodevelopmental Disabilities Physician NPI 1558378067 M.D.
Verify on CMS →

Michael Sherer, M.D.

Neurodevelopmental Disabilities Physician in Fairfax, Virginia.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 62 in Neurodevelopmental Disabilities Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
807
Medicare Part D claims · 37 beneficiaries · Neurodevelopmental Disabilities Physician avg: 1K
Generic prescribing
96%
generic claims · 4% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$207.37
5 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

Michael Sherer, M.D. filed 807 Medicare Part D claims in 2024 as a Neurodevelopmental Disabilities Physician in Fairfax, Virginia, prescribing 96% generic.

807
Part D claims, 2024
96%
generic prescribing
Likely
board-certified (heuristic)
≥72nd
pct by Part D claim volume (lower-bound band)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Michael Sherer, M.D.

Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1558378067), first enumerated 08/01/2006.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 807 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    Board certification signal

    Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.

    Source: NUCC taxonomy + CMS participation heuristic

  • Reported

    Hospital affiliations

    1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.

    Source: CMS Care Compare

  • Reported

    Industry payment transparency

    $207.37 in reported industry payments (5 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.

    Source: CMS Open Payments

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

CMS NPPES provider registry desk

NPI 1558378067 · Neurodevelopmental Disabilities Physician

NPI-10 · ENUM-LEGACY · TAX-TRACE · RX-LIGHT · BOOK-THIN · PHOTO-ENUM

  • NPI-10 1558378067
  • ENUM-LEGACY 2006
  • TAX-TRACE 62
  • RX-LIGHT 807
  • BOOK-THIN 1 in Virginia
  • PHOTO-ENUM Janell Batchellor, M… · 2006

Michael Sherer, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2024, across all CMS prescribers nationally

807 ≥ 72nd percentile 72% of 1,416,883 prescribers are in lower value bands

0–200: 679,947 prescribers (48%). Below this entry. 200–400: 188,835 prescribers (13%). Below this entry. 400–600: 95,866 prescribers (7%). Below this entry. 600–800: 60,107 prescribers (4%). Below this entry. 800–1,000: 43,043 prescribers (3%). This entry sits in this band. 1,000–1,200: 33,612 prescribers (2%). Above this entry. 1,200–1,400: 27,889 prescribers (2%). Above this entry. 1,400–1,600: 23,183 prescribers (2%). Above this entry. 1,600–1,800: 19,917 prescribers (1%). Above this entry. 1,800–2,000: 17,585 prescribers (1%). Above this entry. 2K+: 226,899 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.

Source CMS Medicare Part D Prescriber Public Use File · 2024

Board certification likely (heuristic, not verified)

Michael Sherer, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Michael Sherer, M.D.?

Quality data not reported

NPI registry status

Active

Issued 08/01/2006

NPI 1558378067

Primary specialty

Neurodevelopmental Disabilities Physician

Rare

62 US NPIs in this specialty

Medicare Part D claims

807 34% vs specialty avg

2024 prescription claims

Specialty avg: 1,223

Specialty distribution in Virginia

How Neurodevelopmental Disabilities Physician compares to other specialties among Virginia providers

Virginia providers
Behavior Technician5.5%Clinical Social Worker5.2%Student in an Organized Heal…4.7%Physical Therapist4.6%Pharmacist4.4%Professional Counselor4%Neurodevelopmental Disabilit…0%
Largest specialties in Virginia (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Neurodevelopmental Disabilities Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

9901 BRADDOCK RD
Fairfax, VA 22032

Provider Details

NPI 1558378067
Specialty Neurodevelopmental Disabilities Physician
Credentials M.D.
Gender Male
NPI Issued 08/01/2006

Hospital and facility affiliations

Facilities where Michael Sherer, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Fairfax County, Virginia
Fairfax, VA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Michael Sherer, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$207

Largest payer

E.R. Squibb & Sons, L.L.C.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Generic-heavy

Michael Sherer, M.D. - brand share 4.0%
Neurodevelopmental Disabilities Physician average

4% brand-name claims vs 96% generic, on 807 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

807
Total Claims
$51K
Total Drug Cost
37
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
825.3
Total Day Supply
22,625
Brand vs Generic
4% brand / 96% generic
Brand Drug Cost
$24K
Generic Drug Cost
$27K

Patient Demographics

Average Patient Age
38.7 years
Avg HCC Risk Score
1.07
Age Distribution
<65: 37, 65-74: 0, 75-84: 0, 85+: 0

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

What Michael Sherer, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2024

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2024
Drug Claims
Trazodone Hcl
100
Sertraline Hcl
60
Risperidone
53
Lorazepam
50
Olanzapine
50
Quetiapine Fumarate
47
Clozapine
34
Divalproex Sodium
30
Benztropine Mesylate
27
Haloperidol
26

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Neurodevelopmental Disabilities Physician Overview

How Michael Sherer, M.D. fits within the Neurodevelopmental Disabilities Physician landscape nationally.

62
Neurodevelopmental Disabilities Physician Providers in US
28
States with Neurodevelopmental Disabilities Physician
1,223
Avg Claims per Provider

Michael Sherer, M.D.'s 807 claims are below the specialty average of 1,223.

Nationwide Neurodevelopmental Disabilities Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Sherer, both outside Virginia so the neighborhoods are not geographic containment.

Same NPPES enumeration year (2006)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Frequently Asked Questions

What is Michael Sherer, M.D.'s specialty?
Michael Sherer, M.D. specializes in Neurodevelopmental Disabilities Physician and practices in Fairfax, Virginia. Credentials: M.D..
How much does Michael Sherer, M.D. prescribe under Medicare Part D?
In 2024, Michael Sherer, M.D. wrote 807 Medicare Part D claims totaling $51K in drug costs for 37 beneficiaries.
Where is Michael Sherer, M.D. located?
Michael Sherer, M.D. is located at 9901 BRADDOCK RD, Fairfax, VA, 22032. Phone: (703) 323-4093.
What is Michael Sherer, M.D.'s NPI number?
Michael Sherer, M.D.'s National Provider Identifier (NPI) is 1558378067, issued on 08/01/2006.
Does Michael Sherer, M.D. prescribe more brand-name or generic drugs?
Michael Sherer, M.D.'s prescribing is 4% brand-name and 96% generic drugs by claim count, with $24K in brand drug costs.
How many Neurodevelopmental Disabilities Physician providers are there in the US?
There are 62 Neurodevelopmental Disabilities Physician providers across 28 states in the US. The average Neurodevelopmental Disabilities Physician provider writes 1,223 Medicare Part D claims per year.
What drugs does Michael Sherer, M.D. prescribe most often?
Based on 2024 Medicare Part D data, Michael Sherer, M.D.'s most frequently prescribed drugs include Trazodone Hcl, Sertraline Hcl, Risperidone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Michael Sherer, M.D. accept Medicare?
Michael Sherer, M.D. appears in CMS Medicare data with 807 Part D claims and 37 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Michael Sherer, M.D.'s credentials?
Michael Sherer, M.D.'s NPI is 1558378067 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.